Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
Sponsor: University of the Incarnate Word
This EARLY_PHASE1 trial investigates Glaucoma, Open-Angle and is currently ongoing. University of the Incarnate Word leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting EARLY_PHASE1
-
May 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
▶ Show 1 earlier version
-
Feb 2020 — May 2020 [monthly]
Recruiting EARLY_PHASE1
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of the Incarnate Word
For direct contact, visit the study record on ClinicalTrials.gov .